Elon Musk said on Monday that the first human patient in his Neuralink startup’s clinical trial is recovering well after having a chip implanted in their brain on Sunday.
“Initial results show promising neuron spike detection,” Mr. Musk added in a post on X (formerly Twitter), referring to the activity of neurons that send signals throughout the brain and body.
The San Francisco-based neurotechnology company conducted its first human clinical study using its Precise Robotically Implanted Brain-Computer Interface (PRIME).
Read Full Article Here